Phase I clinical evaluation of a new iron oxide MR contrast agent
Year: 1994
Type: article
Study design: Clinical Trial
Institution: Bristol-Myers Squibb (United States)
Language: English
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W1981616235
